NCT00036517View on ClinicalTrials.gov

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

March 31, 2003

Conditions

Colorectal NeoplasmsDiarrhea

Interventions

DRUG

PHY906

Trial Locations (3)

10021

Weill Cornell Medical Center, New York

29615

Cancer Centers of the Carolinas, Greenville

06516

VA CT Cancer Center, West Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

PhytoCeutica

INDUSTRY